Login / Signup

Disease progression and defects in primary hemostasis as major cause of bleeding in multiple myeloma.

Clemens HinterleitnerAnn-Christin PecherKlaus-Peter KreißelmeierUlrich BuddeLothar KanzHans-Georg KoppKarl Jaschonek
Published in: European journal of haematology (2019)
Bleeding complications in MM are predominantly caused by defects in primary hemostasis and associated with disease progression. In a peri-interventional workup, determination of CTs and VWF:CB/VWF:Ag ratios are of significant importance to assess bleeding risk.
Keyphrases
  • atrial fibrillation
  • multiple myeloma
  • risk factors
  • quantum dots
  • molecularly imprinted
  • solid phase extraction
  • african american
  • high resolution